ABSCI CORP Increase (Decrease) in Accounts Payable
ABSCI CORP (ABSI) reported Increase (Decrease) in Accounts Payable of -$3.09 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-11
- ABSCI CORP increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.05M, a 119.15% decline year-over-year.
- ABSCI CORP increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$2.04M.
- ABSCI CORP increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $37.00K, a 97.64% decline year-over-year.
- ABSCI CORP increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$2.25M.
- ABSCI CORP increase (decrease) in accounts payable for fiscal 2025 was $1.09M, a 36.80% decline from fiscal 2024.
- ABSCI CORP increase (decrease) in accounts payable for fiscal 2024 was $1.73M.
- ABSCI CORP increase (decrease) in accounts payable for fiscal 2023 was -$786.00K.
- ABSCI CORP increase (decrease) in accounts payable for fiscal 2022 was -$533.00K, a 133.86% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$3.09M 10-Q · filed 2026-08-11 | -$3.05M derived: sum of 3 quarters · filed 2026-08-11 | -$5.30M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | -$2.04M 10-Q · filed 2026-05-07 | -$2.00M derived: sum of 2 quarters · filed 2026-05-07 | -$4.25M derived: sum of 3 quarters · filed 2026-05-07 | $1.24M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | $37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$2.21M derived: sum of 2 quarters · filed 2026-03-24 | $3.27M derived: sum of 3 quarters · filed 2026-08-11 | $1.09M 10-K · filed 2026-03-24 | |||
| 2025-09-30 | -$2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $3.24M derived: sum of 2 quarters · filed 2026-08-11 | $1.06M 10-Q · filed 2025-11-12 | $2.63M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $5.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $3.31M 10-Q · filed 2026-08-11 | $4.67M 10-Q · filed 2025-08-12 | $4.88M derived: sum of 3 quarters · filed 2026-08-11 | $4.85M derived: sum of 4 quarters · filed 2026-08-11 | ||
| 2025-03-31 | -$2.18M 10-Q · filed 2026-05-07 | $1.23M 10-Q · filed 2025-05-13 | -$611.00K derived: sum of 2 quarters · filed 2026-05-07 | -$641.00K derived: sum of 3 quarters · filed 2026-05-07 | -$600.00K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $1.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $1.54M derived: sum of 2 quarters · filed 2026-03-24 | $1.58M derived: sum of 3 quarters · filed 2026-03-24 | $1.73M 10-K · filed 2026-03-24 | $2.03M 10-K · filed 2025-03-18 | ||
| 2024-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $11.00K derived: sum of 2 quarters · filed 2025-11-12 | $161.00K 10-Q · filed 2025-11-12 | -$245.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $191.00K 10-Q · filed 2025-08-12 | -$215.00K derived: sum of 3 quarters · filed 2025-08-12 | $290.00K derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $150.00K 10-Q · filed 2025-05-13 | -$256.00K derived: sum of 2 quarters · filed 2025-05-13 | $249.00K derived: sum of 3 quarters · filed 2025-05-13 | -$154.00K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $99.00K derived: sum of 2 quarters · filed 2025-03-18 | -$304.00K derived: sum of 3 quarters · filed 2025-03-18 | -$786.00K 10-K · filed 2025-03-18 | |||
| 2023-09-30 | $505.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $102.00K derived: sum of 2 quarters · filed 2024-11-12 | -$380.00K 10-Q · filed 2024-11-12 | $311.00K derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | -$403.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$885.00K 10-Q · filed 2024-08-14 | -$194.00K derived: sum of 3 quarters · filed 2024-08-14 | -$2.08M derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$482.00K 10-Q · filed 2024-05-14 | $209.00K derived: sum of 2 quarters · filed 2024-05-14 | -$1.67M derived: sum of 3 quarters · filed 2024-05-14 | -$1.65M derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $691.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$1.19M derived: sum of 2 quarters · filed 2024-03-21 | -$1.17M derived: sum of 3 quarters · filed 2024-03-21 | -$533.00K 10-K · filed 2024-03-21 | |||
| 2022-09-30 | -$1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$1.86M derived: sum of 2 quarters · filed 2023-11-14 | -$1.22M 10-Q · filed 2023-11-14 | -$1.20M derived: sum of 4 quarters · filed 2023-11-14 | |||
| 2022-06-30 | $22.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $659.00K 10-Q · filed 2023-08-14 | $688.00K derived: sum of 3 quarters · filed 2023-08-14 | -$511.00K derived: sum of 4 quarters · filed 2023-08-14 | |||
| 2022-03-31 | $637.00K 10-Q · filed 2023-05-15 | $666.00K derived: sum of 2 quarters · filed 2023-05-15 | -$533.00K derived: sum of 3 quarters · filed 2023-05-15 | $953.00K derived: sum of 4 quarters · filed 2023-05-15 | |||
| 2021-12-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.17M derived: sum of 2 quarters · filed 2023-03-30 | $316.00K derived: sum of 3 quarters · filed 2023-03-30 | $1.57M 10-K · filed 2023-03-30 | |||
| 2021-09-30 | -$1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $287.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.54M 10-Q · filed 2022-11-09 | $1.81M derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.74M 10-Q · filed 2022-08-11 | $3.01M derived: sum of 3 quarters · filed 2022-08-11 | $3.63M derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | $1.26M 10-Q · filed 2022-05-11 | $1.52M derived: sum of 2 quarters · filed 2022-05-11 | $2.14M derived: sum of 3 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $263.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $886.00K derived: sum of 2 quarters · filed 2022-03-22 | $903.00K 10-K · filed 2022-03-22 | ||||
| 2020-09-30 | $623.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $640.00K 10-Q · filed 2021-11-09 | |||||
| 2020-06-30 | $17.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |